Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa

Colin P. Sharp, Marion Vermeulen, Yacouba Nebie, Cyrille F. Djoko, Matthew Le Breton, Ubald Tamoufe, Anne W. Rimoin, Patrick K. Kayembe, Jean K. Carr, Annabelle Servant-Delmas, Syria Laperche, G. L. Abby Harrison, Oliver G. Pybus, Eric Delwart, Nathan D. Wolfe, Andrew Saville, Jean-Jacques Lefrere, Peter Simmonds

Research output: Contribution to journalArticlepeer-review


Human parvovirus 4 infections are primarily associated with parenteral exposure in western countries. By ELISA, we demonstrate frequent seropositivity for antibody to parvovirus 4 viral protein 2 among adult populations throughout sub-Saharan Africa (Burkina Faso, 37%; Cameroon, 25%; Democratic Republic of the Congo, 35%; South Africa, 20%), which implies existence of alternative transmission routes.

Original languageEnglish
Pages (from-to)1605-1607
Number of pages3
JournalEmerging Infectious Diseases
Issue number10
Publication statusPublished - Oct 2010


  • Adolescent
  • Adult
  • Africa South of the Sahara
  • Aged
  • Antibodies, Viral
  • Burkina Faso
  • Cameroon
  • Capsid Proteins
  • Child
  • Democratic Republic of the Congo
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parvoviridae Infections
  • Parvovirus
  • South Africa
  • Young Adult

Cite this